Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1

Status

Completed 3Terminated 1

Sponsor Class

NIH 5OTHER 4NETWORK 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 2Gastrointestinal 1Breast 1

Conditions

Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Pain 1Leukoplakia, Oral 1Inflammation 1Hypertension 1Coproporphyria 1Breast Neoplasms 1Adenomatous Polyposis Coli 1

Interventions

Cyclophosphamide 548pembrolizumab 385Radiotherapy 363Bevacizumab 360Carboplatin 351Rituximab 315Cisplatin 300Gemcitabine 297Paclitaxel 288Dexamethasone 272Docetaxel 271fludarabine phosphate 241Doxorubicin 231Nivolumab 220Etoposide 209Cytarabine 203Lenalidomide 201fludarabine 191Oxaliplatin 191Fluorouracil 190Melphalan 189Filgrastim 188Capecitabine 175Calcium Dobesilate 172Radiosurgery 167Erlotinib Hydrochloride 167Methotrexate 163Bortezomib 162Granulocyte Colony-Stimulating Factor 154Whole-Body Irradiation 144

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Has results × Sulindac × Clear all
NCT01761877 2023-02-10

NSAID Effects on Clinical and Imaging Breast Biomarkers

Stony Brook University

Phase 2 Completed
114 enrolled 11 charts
Breast

Breast Neoplasms, Hypertension, Inflammation, Neoplasms, Pain

NCT00299195 2020-11-19

A Randomized Study of Sulindac in Oral Premalignant Lesions

Memorial Sloan Kettering Cancer Center

Phase NA Completed
63 enrolled 10 charts
Head & Neck

Coproporphyria, Leukoplakia, Oral, Neoplasms

NCT00392665 2017-04-13

Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and Neck

Massachusetts General Hospital

Phase 2 Terminated
36 enrolled 10 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT01187901 2016-06-17

FAPEST

University of Utah

Phase 2 Completed
92 enrolled 11 charts
Gastrointestinal

Adenomatous Polyposis Coli

Data powered by HemOnc (CC BY 4.0) Colophon âš¡